Seborrheic keratosis
Chapter 12:Diseases of the skin and subcutaneous tissue
ICD-10 L82 is a used to indicate a diagnosis of seborrheic keratosis.
Seborrheic keratosis (L82) is a common benign skin tumor characterized by the presence of well-defined, scaly, and often pigmented lesions that can vary in color from light tan to black. These lesions typically appear on sun-exposed areas of the body, such as the face, scalp, chest, and back, but can also occur in non-sun-exposed regions. Clinically, seborrheic keratoses are often described as having a 'stuck-on' appearance, and they may be flat or raised. The lesions are generally asymptomatic but can become itchy or irritated. The exact etiology remains unclear, but genetic factors and sun exposure are believed to play significant roles in their development. Seborrheic keratosis is not considered precancerous, but differential diagnosis is essential to rule out other skin conditions, including melanoma and basal cell carcinoma. Diagnosis is primarily clinical, supported by a thorough patient history and physical examination. In some cases, a biopsy may be warranted to confirm the diagnosis, especially if the lesion exhibits atypical features. Regular monitoring is advised, as new lesions may develop over time, particularly in older adults.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L82 specifically covers seborrheic keratosis, which includes various types such as common seborrheic keratosis, atypical seborrheic keratosis, and other benign lesions that fit the clinical description.
L82 should be used when the diagnosis is confirmed as seborrheic keratosis, particularly when lesions are benign and do not exhibit atypical features. If there are signs of malignancy or atypical characteristics, other codes should be considered.
Documentation should include a detailed description of the lesions, their location, size, color, and any symptoms experienced by the patient. Photographic evidence may also support the diagnosis.
